Esteban Patricia Perez, Alves Diana R, Enright Mark C, Bean Jessica E, Gaudion Alison, Jenkins A T A, Young Amber E R, Arnot Tom C
Dept. of Chemical Engineering, University of Bath, Claverton Down, Bath, BA2 7AY, U.K; Dept. of Chemistry, University of Bath, Claverton Down, Bath, BA2 7AY, U.K.
Biotechnol Prog. 2014 Jul-Aug;30(4):932-44. doi: 10.1002/btpr.1898. Epub 2014 Apr 14.
Bacteriophage therapy is a promising new treatment that may help overcome the threat posed by antibiotic-resistant pathogenic bacteria, which are increasingly identified in hospitalized patients. The development of biocompatible and sustainable vehicles for incorporation of viable bacterial viruses into a wound dressing is a promising alternative. This article evaluates the antimicrobial efficacy of Bacteriophage K against Staphylococcus aureus over time, when stabilized and delivered via an oil-in-water nano-emulsion. Nano-emulsions were formulated via thermal phase inversion emulsification, and then bacterial growth was challenged with either native emulsion, or emulsion combined with Bacteriophage K. Bacteriophage infectivity, and the influence of storage time of the preparation, were assessed by turbidity measurements of bacterial samples. Newly prepared Bacteriophage K/nano-emulsion formulations have greater antimicrobial activity than freely suspended bacteriophage. The phage-loaded emulsions caused rapid and complete bacterial death of three different strains of S. aureus. The same effect was observed for preparations that were either stored at room temperature (18-20°C), or chilled at 4°C, for up to 10 days of storage. A response surface design of experiments was used to gain insight on the relative effects of the emulsion formulation on bacterial growth and phage lytic activity. More diluted emulsions had a less significant effect on bacterial growth, and diluted bacteriophage-emulsion preparations yielded greater antibacterial activity. The enhancement of bacteriophage activity when delivered via nano-emulsions is yet to be reported. This prompts further investigation into the use of these formulations for the development of novel anti-microbial wound management strategies.
噬菌体疗法是一种很有前景的新疗法,可能有助于克服耐抗生素病原菌带来的威胁,这类病原菌在住院患者中越来越多地被发现。开发用于将活细菌病毒纳入伤口敷料的生物相容性和可持续载体是一种很有前景的替代方法。本文评估了通过水包油纳米乳液稳定和递送时,噬菌体K对金黄色葡萄球菌随时间变化的抗菌效果。通过热相转变乳化法制备纳米乳液,然后用天然乳液或与噬菌体K结合的乳液挑战细菌生长。通过对细菌样品的浊度测量来评估噬菌体的感染性以及制剂储存时间的影响。新制备的噬菌体K/纳米乳液制剂比自由悬浮的噬菌体具有更强的抗菌活性。负载噬菌体的乳液导致三种不同金黄色葡萄球菌菌株迅速且完全死亡。对于在室温(18-20°C)下储存或在4°C下冷藏长达10天的制剂,也观察到了相同的效果。采用实验的响应面设计来深入了解乳液配方对细菌生长和噬菌体裂解活性的相对影响。稀释度更高的乳液对细菌生长的影响较小,而稀释的噬菌体-乳液制剂产生了更大的抗菌活性。通过纳米乳液递送时噬菌体活性的增强尚未见报道。这促使进一步研究这些制剂在开发新型抗菌伤口管理策略中的应用。